Streetbeat News

Partnerships

MSFT

OpenAI CEO Sam Altman is planning a major AI infrastructure project in the U.S., potentially costing tens of billions of dollars. The project aims to form a global coalition of investors, including those from Canada, Korea, Japan, and the UAE. Microsoft, OpenAI's largest investor, is expected to participate. The project may attract scrutiny from the Committee on Foreign Investment in the U.S.

Portfolio Pulse from Ananya Gairola

September 04, 2024 | 6:29 am

BTCUSD

Pro-cryptocurrency attorney John Deaton has won the Republican nomination for the Massachusetts Senate race against Elizabeth Warren. Deaton, known for his support of Ripple Labs and significant Bitcoin holdings, has received strong backing from the crypto community, including a $1 million Bitcoin donation from the Winklevoss twins and $1.33 million from a crypto-focused super PAC.

Portfolio Pulse from Aniket Verma

September 04, 2024 | 6:12 am

CURLF

The US Cannabis Council (USCC) is advocating for federal cannabis legalization and regulation of hemp-derived intoxicating products. The council, which includes major cannabis companies like Curaleaf, is pushing for changes to the Farm Bill to address regulatory gaps. The debate is particularly heated in Florida, where political figures have conflicting stances on cannabis and hemp regulation. The USCC is also expanding to include hemp manufacturers, anticipating future regulatory changes.

Portfolio Pulse from Rolando García

September 03, 2024 | 11:15 pm

AMZN

BA

LMT

RKLB

The space race between Jeff Bezos and Elon Musk intensifies as Amazon's Project Kuiper secures licenses in New Zealand, potentially collaborating with Rocket Lab. This move challenges Musk's Starlink, which has a significant head start. Bezos is also focusing more on Blue Origin, signaling a deeper rivalry with Musk's SpaceX.

Portfolio Pulse from Chris Katje

September 03, 2024 | 9:19 pm

CLOV

Clover Health's stock surged over 21% in after-hours trading following a multi-year agreement between its subsidiary, Counterpart Health, and The Iowa Clinic. The deal involves providing a cloud-based software platform to clinicians, with potential incentive payments tied to care management goals.

Portfolio Pulse from Adam Eckert

September 03, 2024 | 9:17 pm

ASND

RPRX

Ascendis Pharma's subsidiary has entered into a $150 million capped synthetic royalty funding agreement with Royalty Pharma. This agreement is based on the US net sales of YORVIPATH, a product by Ascendis Pharma.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 9:14 pm

PFE

Acepodia has entered a strategic clinical collaboration with Pfizer Ignite to develop its therapies for autoimmune diseases. Pfizer Ignite will provide strategic guidance and resources, enhancing Acepodia's drug development process.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 9:04 pm

HR

Healthcare Realty Trust has expanded its joint venture with Nuveen, aiming to generate over $1 billion in capital. The new 80/20 joint venture has secured financing for 40% of its contribution value, bringing the total value of joint ventures with Nuveen to over $600 million.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 9:02 pm

CLOV

Clover Health Investments' shares rose following a multi-year agreement between its subsidiary, Iowa Clinic, and Counterpart Health to implement AI technology across Midwest providers.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:43 pm

CLOV

Clover Health Investments' shares rose following the announcement that its subsidiary, Counterpart Health, has secured a multi-year agreement with the Iowa Clinic.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:36 pm